The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
Progresses of chemotherapy in non-small cell lung cancer
Author(s): 
Pages: 242-247
Year: Issue:  4
Journal: World Clinical Drugs

Abstract: 肺癌已成为癌症死亡的主要原因,而非小细胞肺痛(NSCLC)占所有肺癌病例的80%~90%,严重威胁人类健康.化疗在NSCLC的综合治疗中占有非常重要的地位.近年来,化疗药物的快速发展为NSCLC的治疗带来了新的希望.并且已获得大量大规模有力的循证医学证据.
Related Articles
No related articles found